JNJJohnson & Johnson

About Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) is a diversified global healthcare company operating in three key divisions: Consumer, Pharmaceutical, and Medical Devices. Its operations span research & development, manufacturing and selling a broad range of products in the health fields. Projects focus on the development of new drugs, medical devices, digital health solutions and consumer health products. The company's objectives are to help people around the world by creating innovative solutions, improving health outcomes and ensuring access to quality healthcare.
What is JNJ known for?
Snapshot
Public US
Ownership
1886
Year founded
105051
Employees
New Brunswick, United States
Head office
1 of 2
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
New Brunswick, US
Produtos e/ou serviços de Johnson & Johnson
- World-renowned for its comprehensive array of consumer healthcare items, from baby care essentials to skincare products.
- Delivers innovative and critical medical devices, addressing a wide-range of healthcare needs and improving patient care.
- Develops pharmaceuticals treating severe illnesses such as HIV, cancer, and immune disorders, improving and saving lives globally.
- Manufactures and sells the groundbreaking COVID-19 vaccine, offering life-saving protection to millions worldwide.
- Offers vision care products including contact lenses and eye health solutions, enhancing daily sight experiences.
- Committed to global public health solutions, providing disease prevention and health education resources in underprivileged areas.
equipe executiva do Johnson & Johnson
- Mr. Joaquin DuatoCEO & Chairman
- Mr. Joseph J. Wolk CPAExecutive VP & CFO
- Ms. Jennifer L. TaubertExecutive VP & Worldwide Chairman of Innovative Medicine
- Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine and R&D
- Mr. Timothy SchmidExecutive VP & Worldwide Chairman of MedTech
- Mr. Robert J. Decker Jr.Controller & Chief Accounting Officer
- Mr. James SwansonExecutive VP & Chief Information Officer
- Mr. Darren SnellgroveVice President of Investor Relations
- Mr. Dirk BrinckmanChief Compliance Officer
- Ms. Elizabeth Forminard J.D.Executive VP & Chief Legal Officer